论文部分内容阅读
沙曼药厂扩大维恩德的临床试验美国沙曼（Ｓｈａｍａｎ）药厂扩大维恩德（Ｖｉｒｅｎｄ和ＳＰ－３０３）对继发性疱疹感染的爱滋病患者的疱疹局部用药进行研究。该试验目前仅限于对阿昔洛韦（惠康公司的Ｚｏｖｉｒａｘ）耐药的爱滋病患者。沙曼药厂决定在第Ⅰ／Ⅱ期维恩德...
Sharman Expands Clinical Trial in Viende US Shaman Pharmaceuticals Expands Local Herpes Topical Treatment in People with AIDS Infection with Herpes Zoster by Virend and SP-303. The trial is currently limited to AIDS patients who are resistant to acyclovir (Wellcome Inc.’s Zovirax). Sharman Pharmaceuticals decided in the first Ⅰ / Ⅱ Venien ...